Chandigarh: The Head of Minister Haryana, Manohar Lal Khattar on Monday gave approval for notifications related to the reduction of the level of GST goods and services related to Covid-19 treatment and management as recommended by the GST Board.
The GST council, in the 44th meeting held on June 12, 2021, has reduced GST.
This notice will be considered to be valid since June 14, 2021 and will remain valid until and include September 30, 2021.
Sharing further details in this case the official spokesperson said that in accordance with GST level notifications in two drugs, namely Tocilizumab and Amphotericin B will be deleted / excluded fully.
A spokesman said that GST at a level of 2.5% must be collected in 15 other items used in covid treatment such as medical oxygen, remedyivir, heparin (anti-coagulant), covid testing kit, inflammatory diagnostic kit (marker), namely D-Dimer , IL-6, CRP (reactive protein), LDH, Ferritin, pro calcitonin (PCT) and blood gas reagent, hand sanitiser, helmet for use with non-invasive ventilation, gas / electricity / other fabrics for crematoriums, oximeters pulse, devices Nasal Canula (HFNC) Height, oxygen concentrator, ventilator, bipap machine, non-invasive nose or oronasal mask ventilation for ICU ventilators, temporary temperature examination equipment The GST ambulance level has been repaired at 6%.
,
Hry approved the reduction of GST on the MGMT Covid service
